Brief: Turn Therapeutics Announces Corporate And Pipeline Updates And 2026 Outlook Ahead Of The 44Th Annual J.P. Morgan Healthcare Conference
12/01/2026 13:26
Jan 12 (Reuters) - Turn Therapeutics Inc TTRX.O: TURN THERAPEUTICS ANNOUNCES CORPORATE AND PIPELINE UPDATES AND 2026 OUTLOOK AHEAD OF THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Source text: ID:nBw6wXR1Qa Further company coverage: TTRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Turn Therapeutics
See all newsTurn Therapeutics Q2 net loss per share widens on higher R&D costs
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results